A surfactin cyclopeptide of WH1fungin used as a novel adjuvant for intramuscular and subcutaneous immunization in mice

Peptides

Volumn 38, Issue 1, 2012, Pages 163-171

  Gao, Zhenqiu ^a   Wang, Shengying ^b   Qi, Gaofu ^b   Pan, Hui ^b   Zhang, Li ^b   Zhou, Xiaohui ^c   Liu, Jingjing ^a   Zhao, Xiuyun ^b   Wu, Jie ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b HUAZHONG AGRICULTURAL UNIVERSITY   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Adjuvant; Surfactin; Vaccine; WH1fungin

Indexed keywords

FREUND ADJUVANT; GAMMA INTERFERON; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; SURFACTIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; WH1FUNGIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN SPECIFICITY; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; HUMORAL IMMUNITY; IMMUNIZATION; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPLEEN CELL; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL LINE; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; IMMUNOLOGIC MEMORY; INTERFERON-GAMMA; LIPOPEPTIDES; MALE; MICE; MICE, INBRED C57BL; OVALBUMIN; REACTIVE OXYGEN SPECIES; TOLL-LIKE RECEPTOR 2; TUMOR NECROSIS FACTOR-ALPHA;

BACILLUS AMYLOLIQUEFACIENS; MUS;

EID: 84866694710     PISSN: 01969781     EISSN: 18735169     Source Type: Journal    
DOI: 10.1016/j.peptides.2012.08.021     Document Type: Article

References (24)

1. L.J. Braun, A. Tyagi, S. Perkins, J. Carpenter, D. Sylvester, and M. Guy Development of a freeze-stable formulation for vaccines containing aluminum salt adjuvants Vaccine 27 2009 72 79
2. T.W. Clark, M. Pareek, K. Hoschler, H. Dillon, K.G. Nicholson, and N. Groth Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine N Engl J Med 361 2009 2424 2435
3. R.K. Gupta Aluminum compounds as vaccine adjuvants Adv Drug Deliv Rev 32 1998 155 172
4. H. HogenEsch Mechanisms of stimulation of the immune response by aluminum adjuvants Vaccine 20 2002 S34 S39
5. M.H. Hwang, J.H. Lim, H.I. Yun, M.H. Rhee, J.Y. Cho, and W.H. Hsu Surfactin C inhibits the lipopolysaccharide-induced transcription of interleukin-1beta and inducible nitric oxide synthase and nitric oxide production in murine RAW 264.7 cells Biotechnol Lett 27 2005 1605 1608
6. Y.H. Hwang, B.K. Park, J.H. Lim, M.S. Kim, S.C. Park, and M.H. Hwang Lipopolysaccharide-binding and neutralizing activities of surfactin C in experimental models of septic shock Eur J Pharmacol 556 2007 166 171
7. S. Kantengwa, L. Jornot, C. Devenoges, and L.P. Nicod Superoxide anions induce the maturation of human dendritic cells Am J Respir Crit Care Med 167 2003 431 437
8. D.M. Klinman Immunotherapeutic uses of CpG oligodeoxynucleotides Nat Rev Immunol 4 2004 249 259
9. A. Knoblich, M. Matsumoto, R. Ishiguro, K. Murata, Y. Fujiyoshi, and Y. Ishigami Electron cryo-microscopic studies on micellar shape and size of surfactin, an anionic lipopeptide Colloids Surf B Biointerfaces 5 1995 43 48
10. E.B. Lindblad Aluminium adjuvants-in retrospect and prospect Vaccine 22 2004 3658 3668
11. H. Matsue, D. Edelbaum, D. Shalhevet, N. Mizumoto, C. Yang, and M.E. Mummert Generation and function of reactive oxygen species in dendritic cells during antigen presentation J Immunol 171 2003 3010 3018
12. + T cell epitopes fused to heat shock cognate protein 70 (hsc70) can function to eradicate tumors Cancer Sci 99 2008 1008 1015
13. P. Newsholme, E.P. Haber, S.M. Hirabara, E.L. Rebelato, J. Procopio, and D. Morgan Diabetes associated cell stress and dysfunction: role of mitochondrial and non-mitochondrial ROS production and activity J Physiol 583 2007 9 24
14. N. Petrovsky, and J.C. Aguilar Vaccine adjuvants: current state and future trends Immunol Cell Biol 82 2004 488 496
15. G. Qi, F. Zhu, P. Du, X. Yang, D. Qiu, and Z. Yu Lipopeptide induces apoptosis in fungal cells by a mitochondria-dependent pathway Peptides 31 2010 1978 1986
16. F. Rharbaoui, B. Drabner, S. Borsutzky, U. Winckler, M. Morr, and B. Ensoli The mycoplasma-derived lipopeptide MALP-2 is a potent mucosal adjuvant Eur J Immunol 32 2002 2857 2865
17. G. Seydlová, and J. Svobodová Review of surfactin chemical properties and the potential biomedical applications Cent Eur J Med 3 2008 123 133
18. N.S. Shaligram, and R.S. Singhal Surfactin - a review on biosynthesis, fermentation, purification and applications Food Technol Biotechnol 48 2010 119 134
19. R. Spohn, U. Buwitt-Beckmann, R. Brock, G. Jung, A.J. Ulmer, and K.H. Wiesmuller Synthetic lipopeptide adjuvants and toll-like receptor 2-structure-activity relationships Vaccine 22 2004 2494 2499
20. S.K. Straus, and R.E.W. Hancock Mode of action of the new antibiotic for Gram-positive pathogens daptomycin: Comparison with cationic antimicrobial peptides and lipopeptides Biochim Biophys Acta 1758 2006 1215 1223
21. T. Takahashi, O. Ohno, Y. Ikeda, R. Sawa, Y. Homma, and M. Igarashi Inhibition of lipopolysaccharide activity by a bacterial cyclic lipopeptide surfactin J Antibiot 59 2006 35 43
22. R.D. Weeratna, M.J. McCluskie, Y. Xu, and H.L. Davis CpG DNA induces stronger immune responses with less toxicity than other adjuvants Vaccine 18 2000 1755 1762
23. R. Zhou, A.S. Yazdi, P. Menu, and J. Tschopp A role for mitochondria in NLRP3 inflammasome activation Nature 469 2010 221 225
24. X. Zhou, N. Kong, J. Wang, H. Fan, H. Zou, and D. Horwitz All-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu J Immunol 185 2010 2675 2679